Read more
1:20 PM Β· 18 January 2023

Moderna shares higher after RSV vaccine reports πŸ’‰πŸ“ˆ

Moderna
Stocks
MRNA.US, Moderna Inc
-
-

Shares of Moderna (MRNA.US) are trading higher as the company relayed that its vaccine mRNA-1345 against RSV (respiratory syncytial virus) effectively prevents the development of the disease in older adults (phase III research vaccine development results).

  • The company expects to file for approval with the Food and Drug Administration (FDA) in the first half of this year.
  • Moderna shares are up nearly 8% before the Wall Street session and are trading around 205 USD. 

Moderna's shares have been in an uptrend since the company broke the news in the fall of 2022 that it was collaborating with Merck (MRK.US) on a promising anti-cancer therapy. The price on the H1 interval has climbed above the 100 (black line) and 200-session (red line) moving averages, and an opening above $200 could open a path for bulls toward the mid-December highs, when the stock was trading at $217 per share. Moderna will show Q4 2022 results on February 2.

Moderna shares (MRNA.US), H1 interval. Source: xStation5

7 November 2025, 11:43 AM

More Expensive Chips, More Expensive Devices – TSMC is Changing the Rules!

7 November 2025, 10:44 AM

Hensoldt Rises Thanks to Record Backlog and Growth Plans!

6 November 2025, 7:17 PM

Daily summary: Optimism on Wall Street eases againπŸ—½US Dollar drops from recent highs

6 November 2025, 3:41 PM

Venezuela, what would a change in power mean for oil prices?

Join over 2 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the ComissΓ£o de Valores MobiliΓ‘rios (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits